Corrigendum to "Elevated parkinsonism pathological markers in dopaminergic neurons with developmental exposure to atrazine" [Sci. Total Environ. 908 2024: Article 168307]
Sci Total Environ. 2024 Feb 20:912:168805.
doi: 10.1016/j.scitotenv.2023.168805.
Epub 2023 Nov 30.
1 Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, United States of America.
2 Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN 47907, United States of America.
3 Department of Medicinal Chemistry and Molecular Pharmacy, Purdue University, West Lafayette, IN 47907, United States of America.
4 Department of Medicinal Chemistry and Molecular Pharmacy, Purdue University, West Lafayette, IN 47907, United States of America; Purdue Institute of Integrated Neuroscience, Purdue University, West Lafayette, IN 47907, United States of America.
5 School of Health Sciences, Purdue University, West Lafayette, IN 47907, United States of America; Purdue Institute of Integrated Neuroscience, Purdue University, West Lafayette, IN 47907, United States of America.
6 Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, United States of America; Purdue Institute of Integrated Neuroscience, Purdue University, West Lafayette, IN 47907, United States of America; Purdue Center of Cancer Research, West Lafayette, IN 47907, United States of America. Electronic address: cyuan@purdue.edu.